Tag: Neurocrine

Click the tags to see associated articles and topics

View Article Details

Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to "Overweight" by Barclays

Added to Collection on: 2021-05-12 12:56:15

Tags for this article:

Organic compounds

Financial markets

Finance

Click the tags to see associated articles and topics

View Article Details

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Expected to Announce Quarterly Sales of $279.51 ...

Added to Collection on: 2021-05-18 06:42:32

Tags for this article:

Organic compounds

Finance

Economy

Zacks Investment Research

Click the tags to see associated articles and topics

View Article Details

Is Neurocrine Biosciences, Inc. (NBIX) a Smart Choice in Biotechnology Thursday?

Added to Collection on: 2021-06-24 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

XENON PHARMACEUTICALS INC. : Unregistered Sale of Equity Securities, Other Events ...

Added to Collection on: 2022-01-12 13:09:40

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Analysts' Weekly Ratings Updates for Neurocrine Biosciences (NBIX) - ETF Daily News

Added to Collection on: 2021-12-28 13:28:34

Tags for this article:

Drugs

Click the tags to see associated articles and topics

View Article Details

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Sees Large Drop in Short Interest

Added to Collection on: 2023-01-02 11:36:46

Tags for this article:

Short

Stock

Click the tags to see associated articles and topics

View Article Details

Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight - Yahoo Finance

Added to Collection on: 2024-02-10 05:23:29

Tags for this article:

NASDAQ

Click the tags to see associated articles and topics

View Article Details

SEC Form 4 filed by Chief Executive Officer Gano Kyle - Quantisnow

Added to Collection on: 2024-11-02 12:07:16

Tags for this article:

Gano

Board of directors

Kevin Gorman

Kyle Gano

Click the tags to see associated articles and topics

View Article Details

Andrew Ratz, Ph.D., Joins Neurocrine Biosciences as Senior Vice President of Drug ...

Added to Collection on: 2025-01-23 21:25:41

Tags for this article:

Eli Lilly and Company

Andrew Ratz